Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism
- PMID: 20376516
- DOI: 10.1007/s10157-010-0277-0
Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism
Abstract
Background: The autosomal recessive form of pseudohypoaldosteronism type 1 (AR-PHA1) is caused by loss-of-function mutations in the epithelial sodium channel subunit genes and is characterized by a multisystemic and lifelong severe salt-wasting tendency. However, we observed a male AR-PHA1 patient who exhibited less frequent salt wasting with advancing age, despite the cessation of daily salt supplementation.
Objective: To elucidate the mechanism for the above phenomenon.
Methods: We evaluated the sodium-reabsorption ability of his distal nephrons (from the distal convoluted tubules to the collecting ducts) and compared it to that of a patient with the dominant form of PHA1 (AD-PHA1) carrying a heterozygous NR3C2 (mineralocorticoid receptor) gene mutation. In addition, immunoblotting of the thiazide-sensitive Na(+)-Cl(-) cotransporter (NCC) protein was conducted using urine samples from the AR- and AD-PHA1 patients.
Results: The levels of sodium reabsorption that occurred via the distal nephrons were almost identical in the two PHA1 patients, despite their different molecular pathogeneses. Immunoblotting showed an increased urinary NCC protein level in the AR-PHA1 patient.
Conclusion: Taken together, increased sodium reabsorption via the upregulation of the expression of NCC might have been responsible, at least in part, for the clinical improvement seen in an AR-PHA1 patient.
Comment in
-
Clinical improvement in patients with autosomal recessive pseudohypoaldosteronism and the necessity for salt supplementation.Clin Exp Nephrol. 2010 Oct;14(5):518-9. doi: 10.1007/s10157-010-0326-8. Epub 2010 Jul 28. Clin Exp Nephrol. 2010. PMID: 20661616 No abstract available.
Similar articles
-
Dietary potassium restriction attenuates urinary sodium wasting in the generalized form of pseudohypoaldosteronism type 1.CEN Case Rep. 2020 May;9(2):133-137. doi: 10.1007/s13730-019-00441-0. Epub 2020 Jan 3. CEN Case Rep. 2020. PMID: 31900739 Free PMC article. Review.
-
A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.Korean J Pediatr. 2011 Feb;54(2):90-3. doi: 10.3345/kjp.2011.54.2.90. Epub 2011 Feb 28. Korean J Pediatr. 2011. PMID: 21503203 Free PMC article.
-
Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.Endocr J. 2013;60(3):299-304. doi: 10.1507/endocrj.ej12-0330. Epub 2012 Nov 30. Endocr J. 2013. PMID: 23197115
-
Exclusion of serum- and glucocorticoid-induced kinase 1 (SGK1) as a candidate gene for genetically heterogeneous renal pseudohypoaldosteronism type I in eight families.Am J Nephrol. 2007;27(2):164-9. doi: 10.1159/000100107. Epub 2007 Feb 23. Am J Nephrol. 2007. PMID: 17317952
-
[Mineralocorticoid resistance: pseudohypoaldosteronism type 1].Arq Bras Endocrinol Metabol. 2007 Apr;51(3):373-81. doi: 10.1590/s0004-27302007000300004. Arq Bras Endocrinol Metabol. 2007. PMID: 17546235 Review. Portuguese.
Cited by
-
Epithelial sodium channel (ENaC) family: Phylogeny, structure-function, tissue distribution, and associated inherited diseases.Gene. 2016 Apr 1;579(2):95-132. doi: 10.1016/j.gene.2015.12.061. Epub 2016 Jan 7. Gene. 2016. PMID: 26772908 Free PMC article. Review.
-
Clinical improvement in patients with autosomal recessive pseudohypoaldosteronism and the necessity for salt supplementation.Clin Exp Nephrol. 2010 Oct;14(5):518-9. doi: 10.1007/s10157-010-0326-8. Epub 2010 Jul 28. Clin Exp Nephrol. 2010. PMID: 20661616 No abstract available.
-
Systemic pseudohypoaldosteronism-1 with episodic dyslipidemia in a Sudanese child.Endocrinol Diabetes Metab Case Rep. 2021 Jun 1;2021:21-0010. doi: 10.1530/EDM-21-0010. Online ahead of print. Endocrinol Diabetes Metab Case Rep. 2021. PMID: 34165441 Free PMC article.
-
Systemic Pseudohypoaldosteronism Type I: A Case Report and Review of the Literature.Case Rep Pediatr. 2017;2017:7939854. doi: 10.1155/2017/7939854. Epub 2017 Apr 18. Case Rep Pediatr. 2017. PMID: 28484659 Free PMC article.
-
Pseudohypoaldosteronism Type 1 (arPHA1) Treated With Sodium Polystyrene Sulfonate Pretreated Milk.Glob Pediatr Health. 2015 Jan 30;2:2333794X15569301. doi: 10.1177/2333794X15569301. eCollection 2015. Glob Pediatr Health. 2015. PMID: 27335941 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials